Vaccines are an important part of creating “herd immunity” to keep infectious diseases in check. Here are three vaccine developments that have far reaching implications for public health.
The number of Americans who believe vaccinations for diseases like measles and polio are crucial to public health has fallen 10% in the last 10 years (from 80% to 70%), according to a new survey from Research America.
The findings should be concerning for healthcare executives, not only due to the impact non-vaccinations can have on patients, but also due to the high cost.
The economic burden of diseases associated with 10 vaccines recommended by the CDC for adults was $8.95 billion, and unvaccinated people were responsible for almost 80% of that burden ($7.1 billion), according to a Health Affairsstudy.
“Immunizations protect the public from serious diseases and assist in preventing illnesses, disabilities, and even deaths,” says Jennifer Seagle, PharmD, area clinical manager for CompleteRx. “Vaccines, when utilized, have the power to greatly reduce the financial burden on the healthcare global economy.”
Here are three vaccine developments that have far reaching implications.
There are currently 214 vaccines in the pipeline worldwide, says Seagle. “Of those, 40 agents solely prevent influenza. Many vaccines are important during different stages of life and health insurers need to take this into account as they design plans.”
Two vaccines in development could greatly benefit public health. The first is a vaccine in phase 2 clinical trials for the prevention of Staphylococcus aureus infections in patients who are undergoing pre-surgical prophylaxis for elected orthopedic surgery. The second is a vaccine in development for HIV that could be made available as early as 2020.
Erin Bastick, PharmD, RPh, is staff pharmacist at Southwest General Health Center, Middleburg Heights, Ohio.